|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 209.03 USD | +4.96% |
|
+0.27% | +18.77% |
| 04:54am | FDA approves at-home starter dose of Eisai-Biogen Alzheimer's drug | RE |
| 09:40pm | Wedbush Raises Price Target on Biogen to $201 From $196, Keeps Neutral Rating | MT |
| Market Cap | 29.4B 25.79B 23.88B 21.98B 41.57B 2,814B 42.38B 285B 112B 1,382B 110B 108B 4,773B | P/E 2026 * |
32.3x | P/E 2027 * | 16.6x |
|---|---|---|---|---|---|
| Enterprise Value | 34.91B 30.62B 28.36B 26.09B 49.36B 3,341B 50.32B 338B 133B 1,641B 131B 128B 5,667B | EV / Sales 2026 * |
3.47x | EV / Sales 2027 * | 3.15x |
| Free-Float |
85.96% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Biogen Inc.
| 1 day | +5.42% | ||
| 1 week | +0.27% | ||
| Current month | -3.25% | ||
| 1 month | +5.23% | ||
| 3 months | +18.52% | ||
| 6 months | +17.23% | ||
| Current year | +18.77% |
| 1 week | 194.37 |  | 212 |
| 1 month | 193.2 | | 219.72 |
| Current year | 160.36 | | 219.72 |
| 1 year | 121.05 | | 219.72 |
| 3 years | 110.04 | | 281.12 |
| 5 years | 110.04 | | 358.77 |
| 10 years | 110.04 | | 468.55 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 66 | 14/11/2022 | |
Robin Kramer
DFI | Director of Finance/CFO | 60 | 01/03/2025 |
Guy Hadari
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Eric Rowinsky
BRD | Director/Board Member | 69 | 23/03/2010 |
Stephen Sherwin
BRD | Director/Board Member | 77 | 01/01/2010 |
William Hawkins
BRD | Director/Board Member | 72 | 19/06/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 09/06 | Free | Director | 1,505 | 0.0010% | ||
| 09/06 | Free | Director | 1,505 | 0.0010% | ||
| 09/06 | Free | Director | 1,505 | 0.0010% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.96% | +0.27% | +57.04% | -24.80% | 29.4B | |
| -0.22% | +2.04% | +16.21% | -8.03% | 67.61B | |
| -0.63% | -9.21% | +37.82% | +200.20% | 51.6B | |
| +0.36% | +40.00% | +40.00% | +40.00% | 43B | |
| -1.26% | -0.39% | -49.63% | -53.84% | 40.94B | |
| -1.85% | -18.08% | +103.86% | -47.07% | 27.09B | |
| -2.12% | -1.20% | +63.23% | +84.42% | 23.32B | |
| -0.67% | +1.48% | +10.61% | +188.35% | 19.92B | |
| -2.12% | -3.72% | +61.37% | +126.08% | 16.91B | |
| -3.27% | +6.86% | +74.21% | +379.95% | 16.84B | |
| Average | -0.56% | -1.83% | +41.47% | +88.53% | 33.66B | |
| Weighted average by Cap. | -0.33% | -2.34% | +33.27% | +64.01% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 10.06B 8.82B 8.17B 7.52B 14.22B 963B 14.5B 97.39B 38.2B 473B 37.77B 36.95B 1,633B | 10.4B 9.12B 8.45B 7.77B 14.7B 995B 14.99B 101B 39.49B 489B 39.05B 38.19B 1,688B |
| Net income | 1.42B 1.24B 1.15B 1.06B 2B 136B 2.04B 13.71B 5.38B 66.55B 5.32B 5.2B 230B | 1.98B 1.73B 1.61B 1.48B 2.8B 189B 2.85B 19.15B 7.51B 92.94B 7.43B 7.26B 321B |
| Net Debt | 5.51B 4.83B 4.48B 4.12B 7.79B 527B 7.94B 53.34B 20.92B 259B 20.69B 20.23B 894B | 3.38B 2.97B 2.75B 2.53B 4.79B 324B 4.88B 32.77B 12.85B 159B 12.71B 12.43B 549B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/07/26 | USD 209.03 | +4.96% | 2,257,902 |
| 10/07/26 | USD 199.15 | +0.12% | 1,133,120 |
| 09/07/26 | USD 198.91 | -0.72% | 1,657,327 |
| 08/07/26 | USD 200.36 | -2.60% | 1,947,888 |
| 07/07/26 | USD 205.70 | -1.32% | 1,156,880 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BIIB Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
